Wegovy gets FDA approval to reduce risk of heart issues in overweight adults

March 8, 2024

Must read

The FDA on Friday said it approved Novo Nordisk’s popular weight-loss drug Wegovy to reduce the risk of severe heart issues in overweight or obese adults.

Source link

Book Review: Corporate Governance and Responsible Investment in Private Equity

Hackers Found a Simple New Way to Steal a Tesla. Here’s How.

Wegovy gets FDA approval to reduce risk of heart issues in overweight adults

Must read

7 Surprising Inherited Items That Could Be Worth a Fortune

7 Common Retirement Planning Mistakes and How to Avoid Them

4 Signs You’ve Found the Right Financial Advisor — and One Red Flag

Why the Holidays Are Great for Job Searching (and Tips for Success)

More articles

LEAVE A REPLY Cancel reply

Latest article

7 Surprising Inherited Items That Could Be Worth a Fortune

7 Common Retirement Planning Mistakes and How to Avoid Them

4 Signs You’ve Found the Right Financial Advisor — and One Red Flag

Why the Holidays Are Great for Job Searching (and Tips for Success)

22 Apps to Earn Gift Cards For Free

Usefull Links